Bio-Techne Corp
TECH
Market Cap$12.24B
Close$
$38.73
49.7% downside
Current Fair Value
49.7% downsideOvervalued by 49.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.24 Billion |
|---|---|
| Enterprise Value | $12.48 Billion |
| Dividend Yield | $0.32 (0.415314730694354%) |
| Earnings per Share | $1.07 |
| Beta | 1.28 |
| Outstanding Shares | 158,531,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 81.05 |
|---|---|
| PEG | -237.62 |
| Price to Sales | 11.01 |
| Price to Book Ratio | 5.93 |
| Enterprise Value to Revenue | 10.65 |
| Enterprise Value to EBIT | 63.84 |
| Enterprise Value to Net Income | 82 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bio-Techne Corp
2,100 employees
CEO: Charles Kummeth Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014. The company's brands include flagship R&D Systems , No...